China Diabetes Market Report: 2019-2024
China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world.
The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.
China’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
According to the latest report by IMARC Group, titled “China Diabetes Market Report: 2019-2024”, the China diabetes market reached a value of US$ 3.37 Billion in 2018, exhibiting a CAGR of 12.48% during 2011-2018. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in China
Historical, current and future prevalence of type-1 and type-2 diabetes in China
Historical, current and future prevalence of diabetes in the urban and rural regions in China
Historical, current and future prevalence of diabetes among males and females in China
Historical, current and future prevalence of diabetes among various age groups in China
Historical, current and future diagnosis rates for diabetes in China
Historical, current and future drug treatment rates for diabetes in China
Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in China
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in China
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:
Focus of the Analysis:
Performance of the diabetes diagnostics market in China
Market Segmentation
Key players
Market outlook
The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.
China’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
According to the latest report by IMARC Group, titled “China Diabetes Market Report: 2019-2024”, the China diabetes market reached a value of US$ 3.37 Billion in 2018, exhibiting a CAGR of 12.48% during 2011-2018. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in China
Historical, current and future prevalence of type-1 and type-2 diabetes in China
Historical, current and future prevalence of diabetes in the urban and rural regions in China
Historical, current and future prevalence of diabetes among males and females in China
Historical, current and future prevalence of diabetes among various age groups in China
Historical, current and future diagnosis rates for diabetes in China
Historical, current and future drug treatment rates for diabetes in China
Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in China
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in China
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:
Focus of the Analysis:
Performance of the diabetes diagnostics market in China
Market Segmentation
Key players
Market outlook
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 CHINA DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 CHINA DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Overview
7.4.2 Strengths
7.4.3 Weaknesses
7.4.4 Opportunities
7.4.5 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 China Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 China Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast
8 COMPETITIVE LANDSCAPE
8.1 Competitive Structure
8.2 Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 CHINA DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 CHINA DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Overview
7.4.2 Strengths
7.4.3 Weaknesses
7.4.4 Opportunities
7.4.5 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 China Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 China Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast
8 COMPETITIVE LANDSCAPE
8.1 Competitive Structure
8.2 Profiles of Key Players
LIST OF TABLES
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2018 & 2024
Table 3: China: Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 4: China (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 5: China (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 6: China (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 7: China: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - in 000), 2011, 2018 & 2024
Table 8: China: Diabetes Drug Market: Competitive Structure
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2018 & 2024
Table 3: China: Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 4: China (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 5: China (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 6: China (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 7: China: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - in 000), 2011, 2018 & 2024
Table 8: China: Diabetes Drug Market: Competitive Structure
LIST OF FIGURES
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: China: Total Number of Diabetes Patients (in 000), 2011-2018
Figure 6: China: Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 7: China (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 8: China (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 9: China (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 10: China (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 11: China (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 12: China (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 13: China: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, - in 000), 2011-2018
Figure 14: China: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, - in 000), 2019-2024
Figure 15: China: Diabetes Drug Industry Overview
Figure 16: China: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
Figure 17: China: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: China: Diabetes Drug Market: SWOT Analysis
Figure 19: China: Diabetes Drug Market: Value Chain Analysis
Figure 20: China: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: China: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
Figure 22: China: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
Figure 23: China: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
Figure 24: China: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
Figure 25: China: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: China: Oral Antidiabetics Market Forecast : Sales Value (in Million US$), 2019-2024
Figure 27: China: Insulin Market: Sales Value (in Million US$), 2011-2018
Figure 28: China: Breakup of Insulin Market by Class (in %), 2011 & 2018
Figure 29: China: Insulin Market: Sales Share of Key Players (in %)
Figure 30: China: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: China: Total Number of Diabetes Patients (in 000), 2011-2018
Figure 6: China: Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 7: China (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 8: China (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 9: China (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 10: China (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 11: China (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 12: China (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 13: China: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, - in 000), 2011-2018
Figure 14: China: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, - in 000), 2019-2024
Figure 15: China: Diabetes Drug Industry Overview
Figure 16: China: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
Figure 17: China: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: China: Diabetes Drug Market: SWOT Analysis
Figure 19: China: Diabetes Drug Market: Value Chain Analysis
Figure 20: China: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: China: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
Figure 22: China: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
Figure 23: China: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
Figure 24: China: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
Figure 25: China: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: China: Oral Antidiabetics Market Forecast : Sales Value (in Million US$), 2019-2024
Figure 27: China: Insulin Market: Sales Value (in Million US$), 2011-2018
Figure 28: China: Breakup of Insulin Market by Class (in %), 2011 & 2018
Figure 29: China: Insulin Market: Sales Share of Key Players (in %)
Figure 30: China: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024
